Literature DB >> 22517175

Wound healing and glaucoma surgery: modulating the scarring process with conventional antimetabolites and new molecules.

Gábor Holló1.   

Abstract

Subconjunctival absorption of aqueous humor is an essential part of glaucoma filtration surgery. Mitomycin C (MMC) and 5-fluorouracil have been used to reduce postoperative episcleral fibrosis and scar formation in the filtering bleb area for more than two decades. Both antimetabolites have also been frequently injected before needling revision of failing filtering blebs. Recently, MMC was tried also in tube surgery and nonpenetrating filtering surgery, but its usefulness in these applications has not yet been determined. The main complications and side effects of antimetabolite-enhanced filtration surgery comprise development of thin-walled cystic blebs, late bleb leaks, bleb infections, endophthalmitis, chronic hypotony, hypotony maculopathy and corneal epithelial toxicity. Besides MMC and 5-fluorouracil, several other agents were proposed for decreasing episcleral healing after glaucoma filtering surgery. Only few were evaluated in randomized clinical trials, and none became generally accepted or widely used.
Copyright © 2012 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22517175     DOI: 10.1159/000334790

Source DB:  PubMed          Journal:  Dev Ophthalmol        ISSN: 0250-3751


  14 in total

1.  Safety and efficacy of photodynamic therapy using BCECF-AM compared to mitomycin C in controlling post-operative fibrosis in a rabbit model of subscleral trabeculectomy.

Authors:  Azza Mohamed Ahmed Said; Rania Gamal Eldin Zaki; Thanaa Helmy Mohamed; Manal Ibraheem Salman
Journal:  Int J Ophthalmol       Date:  2016-03-18       Impact factor: 1.779

2.  Use of Mitomycin C for Refractory Esophageal Stricture following Tracheoesophageal Fistula Repair.

Authors:  Anna Lakoma; Sara C Fallon; Shawn Mathur; Eugene S Kim
Journal:  European J Pediatr Surg Rep       Date:  2013-03-19

3.  European Glaucoma Society Terminology and Guidelines for Glaucoma, 4th Edition - Chapter 3: Treatment principles and options Supported by the EGS Foundation: Part 1: Foreword; Introduction; Glossary; Chapter 3 Treatment principles and options.

Authors: 
Journal:  Br J Ophthalmol       Date:  2017-06       Impact factor: 4.638

4.  A Comparative Study: The Use of Collagen Implant versus Mitomycin-C in Combined Trabeculotomy and Trabeculectomy for Treatment of Primary Congenital Glaucoma.

Authors:  Alaa Abdel Sadek Singab; Osama Ali Mohammed; Mohammed Iqbal Hafez Saleem; Mortada Ahmed Abozaid
Journal:  J Ophthalmol       Date:  2017-04-23       Impact factor: 1.909

5.  Suppression of TGF-β pathway by pirfenidone decreases extracellular matrix deposition in ocular fibroblasts in vitro.

Authors:  Thomas Stahnke; Bhavani S Kowtharapu; Oliver Stachs; Klaus-Peter Schmitz; Johannes Wurm; Andreas Wree; Rudolf Friedrich Guthoff; Marina Hovakimyan
Journal:  PLoS One       Date:  2017-02-23       Impact factor: 3.240

6.  Effects of topical bevacizumab application on early bleb failure after trabeculectomy: observational case series.

Authors:  Justyna Klos-Rola; Maria Tulidowicz-Bielak; Tomasz Zarnowski
Journal:  Clin Ophthalmol       Date:  2013-09-25

Review 7.  Ologen implant versus mitomycin C for trabeculectomy: a systematic review and meta-analysis.

Authors:  Miao He; Wei Wang; Xiulan Zhang; Wenyong Huang
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

8.  In vitro mitomycin C absorption and delivery with different sponge materials used in filtering surgery.

Authors:  Diana Urbaneja; Antonio Morilla-Grasa; Elisa Jimenez; Judith Montemayor; Nuria Marcobal; Carme Aragay; Celia Gurdiel; Marta Armillas; Pere Ortiz; Alfonso Antón
Journal:  Clin Ophthalmol       Date:  2016-04-15

Review 9.  Pathobiology of wound healing after glaucoma filtration surgery.

Authors:  Osamu Yamanaka; Ai Kitano-Izutani; Katsuo Tomoyose; Peter S Reinach
Journal:  BMC Ophthalmol       Date:  2015-12-17       Impact factor: 2.209

10.  Silencing of ILK attenuates the abnormal proliferation and migration of human Tenon's capsule fibroblasts induced by TGF-β2.

Authors:  Yao Xing; Lijun Cui; Qianyan Kang
Journal:  Int J Mol Med       Date:  2016-06-16       Impact factor: 4.101

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.